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Serum total sialic acid, lipid peroxidation, and glutathione
reductase levels in patients with rheumatoid arthritis
Surapaneni Krishna MOHAN1, Vishnu PRIYAV2

Aim: The changes in the serum sialic acid levels, total lipid peroxidation products (MDA), and glutathione reductase
activity were estimated in patients with rheumatoid arthritis. Serum Sialic acid is known as a parameter of inflammation.
This work was undertaken to assess the potential role of sialic acid as well as oxidative stress and antioxidant status in
patients with rheumatoid arthritis.
Materials and methods: The levels of these parameters in serum were studied in 52 subjects with rheumatoid arthritis
(study subjects) and 52 age and sex matched healthy subjects as controls. Serum total sialic acid levels were determined
using the assay method described by Warren. Serum MDA was determined as the measure of thiobarbituric acid reactive
substances (TBARS) and glutathione reductase activity was measured in the serum by the method described by Goldberg
DM.
Results: It was observed that there was a significant increase in serum sialic acid, MDA levels, and glutathione reductase
activity in patients with rheumatoid arthritis compared to controls.
Conclusion: The results of our study suggest higher oxygen free radical production, evidenced by increased MDA support
to the oxidative stress in rheumatoid arthritis. The increased activities of antioxidant enzymes may be a compensatory
regulation in response to increased oxidative stress. The results suggest the antioxidant activity of sialic acid in response
to the increased oxidative stress in rheumatoid arthritis.
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Introduction
Arthritis, the joint inflammation, refers to a group of diseases that cause pain, swelling, stiffness,
and loss of motion in the joints. Rheumatoid Arthritis (RA) is a chronic, systemic disease, in which
various joints in the body are inflamed, leading to swelling, pain, stiffness, and a possible loss of
function. It is an autoimmune disease in which the body’s immune system attacks itself. RA affects
approximately 1%-2% of the total world’s population (1). Annual incidence rate of RA between
0.5%-1% of the total population is reported every year in both developed and developing countries
(2). Lower incidences of RA are reported every year in East Asia (3). RA affects around 1 in 50
people and is more common in women than men. It is most common after the age of 40, but can
happen at any age. Sialic acid is an acetylated derivative of neuraminic acid and it is attached to nonreducing residues of carbohydrate chains of glycoproteins and glycolipids. Serum sialic acid has
been reported as a marker of the acute phase response; increased sialic acid concentrations have
been observed in several diseases, such as myocardial infarction and diabetes. Serum sialic acid is
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also increased during inflammatory processes as a
consequence of elevated concentrations of richly
sialylated acute phase glycoproteins (4). Serum sialic
acid was reported to be a useful parameter of
inflammation (5). On the other hand some studies
reported that the monomeric sialic acid is a potent
defense molecule against oxidative damage and cell
death caused by H2O2 (6). However, its significance
has not been discussed in various pathological
conditions. Since the oxidative damage caused by free
radicals is a pivotal mechanism in the progression of
RA, the relation between sialic acid levels and
oxidant–antioxidant status was evaluated. Lipid
peroxidation mediated by free radicals is considered
to be a major mechanism of cell membrane
destruction and cell damage. Free radicals are formed
in both physiological and pathological conditions in
mammalian tissues (7). The uncontrolled production
of free radicals is considered as an important factor in
the tissue damage induced by several
pathophysiologies (8,9). Alteration in the oxidant–
antioxidant profile is known to occur in rheumatic
diseases (10,11). Oxidative stress due to damage
brought about by free radicals is also known to
influence the response of these patients to therapy.
Moreover, the body’s defense mechanisms would play
an important role in the form of antioxidants and try
to minimize the damage, adapting itself to the above
stressful situation. Antioxidants are compounds that
dispose, scavenge, and suppress the formation of free
radicals, or oppose their actions (12) and 2 main
categories of antioxidants are those whose role is to
prevent the generation of free radicals and those that
intercept any free radicals that are generated (13).
They exist in both aqueous and membrane
compartments of cells and can be enzymes or nonenzymes. The aim of our study was to investigate the
changes in oxidant and antioxidant status and its
relation with sialic acid in patients with RA.

Out of the 52 patients included in the study 12 are
females. An equal number of age and sex matched
healthy subjects with a similar socio-economic status
were also investigated. The females of the study group
were matched with females of the control. As
menopause and female sex hormones and their
receptors play a major role in oxidant status and
arthritis, menopause in females was considered for
matching. Body weight was also taken into
consideration. Due permission was obtained from the
ethical committee of the institution before the start of
the study. Written consents were also obtained from
the patients prior to the study and the objectives of
the study were fully explained. Four of the
participants dropped out at the end of the selection as
they did not like the idea of giving blood.
Complete clinical and personal history of the
subjects was recorded. The subjects were 35–60 years
old. All patients in the study were clinically diagnosed
as patients with RA. The presence of RA in patients
was diagnosed via X – ray analysis of joint
destruction, rheumatoid factor test, C–reactive
protein, and antinuclear anti bodies test. None of
these subjects was alcoholics or chronic smokers and
did suffer from any systemic diseases like
hypertension or any diabetic complication. Patients
suffering from a disease of any origin other than
osteoarthritis were excluded from the study. Subjects
with normal nutritional habits without supplementing
any vitamins during the prior 6 months were
included. Subjects with history of receiving antiinflammatory drugs in the prior 6 months and history
or present symptoms of any other stress induced
disorder were excluded.
The controls and patients were divided into 2
groups.
Group 1: Fifty-two healthy age and sex matched
controls with similar a
socio economic status.

Materials and methods
The study was conducted in the Department of
Biochemistry, Saveetha Medical College & Hospital,
Saveetha University, Chennai, T.N, India. Fifty-two
clinically diagnosed patients from orthopedics
department, who had not undergone any previous
treatment for their arthritis, were chosen for the study.
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Group 2: Fifty-two patients with clinically
diagnosed RA.
The venous blood samples obtained from these
subjects in the morning after an overnight fasting
were used for analysis. Serum was separated by
centrifugation at 1000 g for 15 min at +4 °C. Separated
serum was used for the estimation of sialic acid,
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Chemicals
All reagents used were of analytical reagent grade
or the highest grade available. Glutathione and
thiobarbituric acid were obtained from sigma
chemicals, St.Louis, MO, USA. Statistical analysis
between group 1 (controls) and group 2 (patients) was
performed by the Mann Whitney U test. The data are
expressed as mean ± SD. P < 0.05 was considered as
significant.
Statistical analysis
Statistical analysis between group 1 (controls) and
group 2 (patients) was performed by the Independent
Student’s t test using SPSS for Windows version 15.
The data are expressed as mean ± SD. P < 0.05 was
considered as significant.
Results
Mean ± SD of total sialic acid, malondialdehyde
(MDA) levels, and activity of glutathione reductase in
controls and patients with RA described in Table1 and
Figure 1. There was a statistically significant increase
in the serum total sialic acid and malondialdehyde
(MDA) levels, and glutathione reductase activity in
patients with RA compared to controls.
Table 1. Mean ± SD values of total sialic acid and
malondialdehyde (MDA) levels, and glutathione
reductase activity in controls and patients with RA.

Parameter

Group 1
(controls)
n = 52

Group 2
(Patients)
n = 52

25.33 ± 0.81
4.89 ± 0.89
35.05 ± 1.62

59.98 ± 0.58***
6.61 ± 0.54***
57.92 ± 1.22***

Discussion
In the present study the lipid peroxidation
product, i.e. MDA, levels were increased significantly
in the serum of the patients with RA. Rise in MDA
could be due to increased generation of reactive
oxygen species (ROS) due to the excessive oxidative
damage generated in these patients. These oxygen
species in turn can oxidize many other important
biomolecules including membrane lipids. Similar
reports of elevated MDA levels have been reported in
patients with rheumatic disease (11,17). In contrast to
our study, Kajanachumpol et al. reported no
significant change in MDA levels in patients with RA
compared to controls (18).
We observed a significant increase in the serum
total sialic acid levels in patients with RA compared to
controls. In our study total serum sialic acid levels
were significantly increased parallel to oxidative
stress. So, we suggest that increased levels of sialic acid
levels might be considered as a defense molecule
against the increased oxidative stress in RA.
Antioxidant property of Sialic acid as a H2O2
scavenger has been reported by Tanaka et al. (19).
In our study the erythrocyte antioxidant enzyme,
i.e. glutathione reductase activity, has been increased
significantly in patients with RA. Similar reports of
raised antioxidant enzyme activities have been
reported in patients with RA (10,20). Glutathione
reductase (GR), an oxidative stress inducible enzyme,
plays a significant role in the peroxyl scavenging
mechanism and in maintaining functional integration
of the cell membranes (21). The rise in the activity of
GR could be due to its induction to counter the effect
of increased oxidative stress.

Mean ± SD

MDA, and glutathione reductase. Serum total sialic
acid levels were determined using the thiobarbituric
acid assay method described by Warren (14). Serum
MDA was determined as the measure of
thiobarbituric acid reactive substances (TBARS) (15)
and glutathione reductase activity was measured in
the serum by the method described by Goldberg DM
(16). Necessary care was taken during sample
collection, storage, and assay.
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Figure 1. Mean ± SD values of total sialic acid and
malondialdehyde (MDA) levels and glutathione
reductase activity in controls and patients with RA.

539

Serum total sialic acid, status in rheumatoid arthritis

In conclusion, oxidative stress may be involved in
RA. There is a shift in the oxidant–antioxidant
balance in favor of lipid peroxidation, which could
lead to the tissue damage observed in this disease. The
results of our study suggest higher oxygen free radical
production, as evidenced by significant increase in
malondialdehyde levels, supports the higher oxidative

stress hypothesis in RA. The increased activities of
antioxidant enzymes may be a compensatory
regulation in response to increased oxidative stress.
Furthermore, serum total sialic acid levels increased
in parallel to oxidative stress, supporting the role of
sialic acid as an antioxidant.
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